Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data READING INTERNATIONAL INC files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
271
280
309
277
77.9
139
203
223
211
203
Cost of revenue
215
224
245
Gross profit
55.9
55.1
64.2
General and administrative
26.9
25.3
27.3
25.4
17
25.1
21.4
20.2
20.2
19.3
Operating income
20.7
20.4
23.6
9.12
-61.3
-41.8
-28.5
-12
-14
-5.31
Interest expense
6.78
6.19
6.84
7.9
9.35
13.7
14.4
19.4
21.2
17.9
Interest income
0.09
Other non-operating income
-0.06
0.59
-0.26
0.33
0.29
3.76
6.82
-0.16
1.53
-2.18
Pre-tax income
13.8
34.2
17.5
2.33
-70.8
40.8
-35.8
-30.6
-35.4
-13.8
Income tax
4.14
3.29
3.3
28.8
-4.97
5.94
0.82
0.59
0.48
0.85
Net income to minority interests
0.01
0.01
0.13
-0.07
-0.66
2.89
-0.48
-0.51
-0.6
-0.51
Net income
9.68
30.9
14
-26.4
-65.2
31.9
-36.2
-30.7
-35.3
-14.1
EBITDA
36.4
37.3
45.9
31.9
-39
-19
-7.57
6.39
1.75
7.89
EPS, basic
0.42
1.34
0.61
-1.17
-3.00
1.46
-1.64
-1.38
-1.58
-0.62
EPS, diluted
0.41
1.33
0.60
-1.17
-3.00
1.42
-1.64
-1.38
-1.58
-0.62
Shares, basic (weighted)
23.3
23
23
22.6
21.7
21.8
22
22.2
22.4
22.7
Shares, diluted (weighted)
23.5
23.2
23.2
22.8
22.2
22.4
22
22.2
22.4
22.7
Balance sheet
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
19
13.7
14.5
12.1
26.8
83.3
29.9
12.9
12.3
10.5
Short-term investments
0.05
0.05
0.04
0.05
0.03
0.02
0.02
0.02
0.01
0.01
Receivables
8.77
13.1
8.05
7.09
2.44
5.36
6.21
7.56
5.28
4.55
Inventory
1.39
1.43
1.42
1.67
1.06
1.41
1.62
1.65
1.69
1.66
Other current assets
5.79
5.33
7.67
6.11
8.41
4.87
3.8
2.88
2.67
2.28
Total current assets
72.6
33.5
30.3
27
56.5
100
47.5
38.7
57
21.8
Property, plant and equipment
212
265
258
258
353
307
287
262
215
208
Lease right-of-use assets
230
221
227
200
182
161
160
Goodwill
19.8
20.3
19.4
26.4
28.1
26.8
25.5
25.5
23.7
24.6
Intangible assets
10
8.54
7.37
4.32
3.97
3.26
2.39
2.04
1.8
1.58
Other non-current assets
13.9
5.08
6.13
6.67
8.03
6.46
10.3
8.97
8.8
13.4
Total assets
406
423
439
675
690
688
587
533
471
435
Accounts payable
26.5
34.4
26.9
29.4
38.9
39.7
42.6
43.8
48.7
52.8
Deferred revenue
10.8
9.85
9.26
11.3
10.1
10
10.3
11
9.73
11.3
Short-term debt
47.2
85.5
69.2
36
Total current liabilities
66
80.4
86.3
111
121
107
122
127
162
129
Long-term debt
116
94.9
106
141
214
195
149
147
105
114
Lease liabilities
223
213
223
200
181
162
163
Other non-current liabilities
30.2
26.6
28.9
18.9
22
22.9
19.3
11.7
13.7
13.1
Total liabilities
259
242
259
535
609
583
524
500
476
453
Total debt
149
135
167
209
285
237
216
210
203
185
Paid-in capital
145
146
147
149
150
152
154
155
158
155
Retained earnings
1.68
33.1
47
20.6
-44.6
-12.6
-48.8
-79.5
-115
-129
Treasury stock
-16.4
-22.9
-25.2
-39.7
-40.4
-40.4
-40.4
-40.4
-40.4
-40.4
Other comprehensive income
12.1
21
6.12
5.59
12.5
4.88
-1.96
-2.67
-7.17
-4.61
Shareholders' equity
142
177
176
135
77.8
104
62.9
33.1
-4.36
-18.2
Minority interests
4.42
4.33
4.34
4.27
3.4
0.99
0.42
-0.09
-0.43
0.14
Total equity
147
181
180
140
81.2
105
63.3
33
-4.79
-18.1
Total liabilities and equity
406
423
439
675
690
688
587
533
471
435
Cash flow statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
9.69
30.9
14.2
-26.5
-65.9
34.8
-36.7
-31.2
-35.9
-14.7
Depreciation and amortization
15.7
16.9
22.3
22.7
22.3
22.7
20.9
18.4
15.8
13.2
Stock-based compensation
0.61
1
1.46
1.46
1.42
2.15
1.89
1.86
2.36
1.91
Deferred income tax
-4.2
3.29
-3.54
22.6
-3.51
0.88
1.38
0.41
-1
-1.58
Change in receivables
1.3
-3.09
2.87
0.7
4.81
-2.82
0.98
-1.33
2.1
-1.17
Change in payables
2.84
-3.42
2.56
0.51
9.33
6.31
0.81
1.07
9.79
7.67
Cash from operations
30.2
23.9
32.6
24.6
-30.2
-13.5
-26.4
-9.74
-3.83
-1.58
Capital expenditures
-49.2
-65.9
-63.5
-45.7
-18.5
-15.6
-9.39
-4.47
-5.54
-1.33
Acquisitions
-7.88
Cash from investing
-42.9
-6.79
-64.9
-53.3
-18.8
130
-9.49
-2.7
3.96
37.1
Debt issued
81.6
91
90.9
90.5
90.3
45.3
4.14
16
Debt repaid
-63.7
-106
-54.4
-52.4
-29.9
-88.4
-16
-9.67
-15.3
-36.8
Stock issued
0.15
0.05
0.34
Share buybacks
-2.85
-6.53
-2.32
-11.2
-0.67
Cash from financing
11.2
-22.1
33.2
26
59.3
-50.3
-16.6
-6.67
0.34
-37.9
Exchange rate effect
0.74
-0.36
-1.54
0.32
4.33
-4.1
-1.2
-0.44
-0.82
0.13
Net change in cash
-0.69
-5.35
-0.54
-2.33
14.7
61.7
-53.6
-19.5
-0.36
-2.22
Free cash flow
-19
-42.1
-30.9
-21.1
-48.7
-29.1
-35.7
-14.2
-9.37
-2.91
Interest paid
5.95
4.88
8.04
10.7
10.2
12.4
13.1
18.5
19.5
15.9
Income taxes paid
6.61
9.25
8.94
7.04
-2.33
-6.48
9.39
-0.64
1.9
2.55
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $16.37 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Operating margin
1.2%
Operating income / revenue.
EBITDA margin
7.2%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-5.3%
Pre-tax income / revenue.
Net margin
-5.9%
Net income / revenue.
FCF margin
1.5%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
2.5%
Cash from operations / revenue.
Return on assets (ROA)
-2.9%
Net income / average total assets.
Stock-based pay / revenue
0.7%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
1.0%
Capital expenditures / revenue.
D&A / revenue
6.0%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-3.6%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-0.0%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
21.1%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y
351.9%
EBITDA vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
-7.7%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-9.5%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
-8.8%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
1.1%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
0.9%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
0.4%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.23x
Current assets / current liabilities.
Quick ratio
0.06x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.03x
(Cash + short-term investments) / current liabilities.
Capital expenditures / cash from operations, when that is positive.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$0.53
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$8.99
Revenue / diluted weighted shares.
FCF per share
$0.13
Free cash flow / diluted weighted shares.
Operating cash flow per share
$0.22
Cash from operations / diluted weighted shares.
Book value per share
-$0.98
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
1.75x
Market cap / revenue.
P/FCF
118x
Market cap / free cash flow. Only when free cash flow is positive.
P/OCF
71.3x
Market cap / cash from operations, when positive.
EV/Sales
1.72x
Enterprise value / revenue.
EV/EBIT
145x
Enterprise value / operating income, when both are positive.
EV/EBITDA
24.0x
Enterprise value / EBITDA, when both are positive.
EV/FCF
117x
Enterprise value / free cash flow, when both are positive.
FCF yield
0.8%
Free cash flow / market cap.
Earnings yield
-3.4%
Net income / market cap (the inverse of P/E).
What was READING INTERNATIONAL INC's revenue in fiscal 2025?
READING INTERNATIONAL INC reported revenue of $203.0M for fiscal 2025, 3.6% lower than the year before.
Was READING INTERNATIONAL INC profitable in fiscal 2025?
No. It reported a net loss of $14.1M.
How much free cash flow did READING INTERNATIONAL INC generate in fiscal 2025?
Cash from operations of $1.6M minus capital expenditures of $1.3M left free cash flow of -$2.9M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.